Serina Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Serina Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 72% to $142,000. Profit margin reached -10425%. Total operating expenses were $9,931,000.
Profit Margin
| 2017 | 1.40M | -6.58M | -468.66% |
|---|---|---|---|
| 2019 | 1.72M | -12.15M | -703.36% |
| 2020 | 54K | -10.86M | -20120.37% |
| 2021 | 3.03M | -1.26M | -41.61% |
| 2022 | 500K | -2.68M | -536.42% |
| 2023 | 142K | -14.80M | -10424.65% |
SER Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 142K | 500K | 3.03M | 54K | 1.72M | 1.40M |
Cost of revenue | 171K | 145K | 150K | 1.28M | 998.5K | 685K |
Gross profit | -29K | 355K | 2.88M | -1.22M | 729.5K | 719K |
Operating exp. | ||||||
Research and development | 603K | 1.57M | 3.79M | 3.58M | 5.34M | 5.26M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 9.93M | 2.77M | 4.67M | 9.18M | 13.28M | 9.13M |
Operating income | -9.96M | -2.27M | -1.63M | -10.40M | -12.55M | -8.41M |
Other income (expenses), net | -4.85M | -397.61K | 359.04K | 8K | 323K | 1.78M |
Income before tax | -14.81M | -2.68M | -1.26M | -10.39M | -12.23M | -6.63M |
Income tax expense | -8K | -250.03K | 3.09K | 466K | 148K | -57K |
Net income | -14.80M | -2.68M | -1.26M | -10.86M | -12.15M | -6.58M |
Earnings per share | ||||||
Basic EPS | -13.72 | -2.49 | -1.17 | -10.14 | -11.47 | -6.46 |
Diluted EPS | -13.72 | -2.49 | -1.17 | -10.14 | -11.47 | -6.46 |